nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
B-cell–specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice
|
Knittel, Gero |
|
|
127 |
22 |
p. 2732-2741 |
artikel |
2 |
Blood's 70th anniversary: musings of a Blood editor, 2003-2007
|
Shattil, Sanford J. |
|
|
127 |
22 |
p. 2649-2651 |
artikel |
3 |
Cardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury–associated coagulopathy in mice
|
Zhao, Zilong |
|
|
127 |
22 |
p. 2763-2772 |
artikel |
4 |
Chen Z, Orlowski RZ, Wang M, Kwak L, McCarty N. Osteoblastic niche supports the growth of quiescent multiple myeloma cells. Blood. 2014;123(14):2204-2208.
|
|
|
|
127 |
22 |
p. 2777 |
artikel |
5 |
Cytogenetics in CML: more important than you think
|
Guilhot, François |
|
|
127 |
22 |
p. 2661-2662 |
artikel |
6 |
Deformation of erythroblasts in transient erythroblastopenia of childhood caused by HHV-6
|
Ogawa, Akira |
|
|
127 |
22 |
p. 2776 |
artikel |
7 |
Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome
|
Hyvärinen, Satu |
|
|
127 |
22 |
p. 2701-2710 |
artikel |
8 |
4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells
|
Yun, Seongseok |
|
|
127 |
22 |
p. 2711-2722 |
artikel |
9 |
Editorial Board
|
|
|
|
127 |
22 |
p. i |
artikel |
10 |
Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism
|
Joshi, Nikita |
|
|
127 |
22 |
p. 2751-2762 |
artikel |
11 |
Fibrin fixes fibrosis
|
Lisman, Ton |
|
|
127 |
22 |
p. 2662-2664 |
artikel |
12 |
Gill JC, Castaman G, Windyga J, et al. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015;126(17):2038-2046.
|
|
|
|
127 |
22 |
p. 2777 |
artikel |
13 |
GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo
|
Healy, Jane A. |
|
|
127 |
22 |
p. 2723-2731 |
artikel |
14 |
Goodman JW, Hodgson GS. Evidence for stem cells in the peripheral blood of mice. Blood. 1962;19(6):702-714.
|
|
|
|
127 |
22 |
p. 2653 |
artikel |
15 |
Hemophagocytic lymphohistiocytosis secondary to iatrogenic disseminated histoplasmosis
|
Dao, Linda N. |
|
|
127 |
22 |
p. 2775 |
artikel |
16 |
How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation
|
Waghmare, Alpana |
|
|
127 |
22 |
p. 2682-2692 |
artikel |
17 |
Mouse model of MYD88L265P-dependent DLBCL
|
Janz, Siegfried |
|
|
127 |
22 |
p. 2660-2661 |
artikel |
18 |
mTOR signaling: new networks for ALL
|
Fruman, David A. |
|
|
127 |
22 |
p. 2658-2659 |
artikel |
19 |
Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots
|
Sala Torra, Olga |
|
|
127 |
22 |
p. 2773-2774 |
artikel |
20 |
Personalized medicine in thrombosis: back to the future
|
Nagalla, Srikanth |
|
|
127 |
22 |
p. 2665-2671 |
artikel |
21 |
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1
|
Richardson, Paul G. |
|
|
127 |
22 |
p. 2693-2700 |
artikel |
22 |
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|
Emile, Jean-François |
|
|
127 |
22 |
p. 2672-2681 |
artikel |
23 |
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
|
Wang, Wei |
|
|
127 |
22 |
p. 2742-2750 |
artikel |
24 |
Sweeteners for factor H
|
Conway, Edward M. |
|
|
127 |
22 |
p. 2656-2658 |
artikel |
25 |
The histiocytoses: as easy as ABC (or LCMRH)
|
Frater, John L. |
|
|
127 |
22 |
p. 2655-2656 |
artikel |